Search is restricted to the following diseases:
Search Results for "KLF15" - 38 interactions found in 8 entries.
|
|
|
Interactor1 (Subject) |
|
Interaction type |
Interactor2 (Object) |
additional information |
|
|
|
|
5,610
|
| 53816 |
KLF15
|
|
is_expressed_in
|
adipose tissue
|
|
| 53818 |
KLF15
|
|
increases_expression of
|
UCP1
|
|
|
20709022
|
Diabetes mellitus, type II
Insulin resistance
|
|
6,456
|
| 61207 |
Metformin
|
|
decreases_expression of
|
KLF15
|
|
| 61210 |
Metformin
|
|
decreases_quantity of
|
KLF15
|
via increased degradation
|
|
22117616
|
Diabetes mellitus, type II
Cancer
Insulin resistance
|
|
6,464
|
| 61211 |
KLF15
|
|
affects_activity of
|
gluconeogenesis
|
|
| 61212 |
KLF15
|
|
affects_activity of
|
cellular amino acid catabolic process
|
|
| 61213 |
KLF15
|
|
affects_activity of
|
hyperglycemia
|
|
| 61214 |
Metformin
|
|
decreases_expression of
|
KLF15
|
|
| 61215 |
Metformin
|
|
decreases_quantity of
|
KLF15
|
via increased degradation
|
| 61216 |
KLF15
|
|
increases_expression of
|
PCK1
|
in liver
|
| 61217 |
KLF15
|
|
increases_expression of
|
HPD
|
in liver
|
| 61218 |
KLF15
|
|
increases_expression of
|
G6PC
|
in liver
|
| 61219 |
KLF15
|
NOT |
affects_expression of
|
CREB1
|
in liver
|
| 61220 |
KLF15
|
NOT |
affects_expression of
|
PPARGC1A
|
in liver
|
| 61221 |
KLF15
|
NOT |
affects_expression of
|
CRTC2
|
in liver
|
| 61222 |
KLF15
|
|
interacts (colocalizes) with
|
PPARGC1A
|
in liver
|
| 61223 |
KLF15
|
NOT |
affects_expression of
|
SLC2A2
|
in liver
|
| 61224 |
KLF15
|
NOT |
affects_expression of
|
GCK
|
in liver
|
| 61225 |
KLF15
|
NOT |
affects_expression of
|
PKLR
|
in liver
|
| 61226 |
KLF15
|
|
affects_expression of
|
GPT
|
in liver
|
| 61227 |
KLF15
|
|
affects_expression of
|
TDO2
|
in liver
|
| 61228 |
KLF15
|
|
affects_expression of
|
PRODH
|
in liver
|
| 61229 |
KLF15
|
NOT |
affects_activity of
|
hyperglycemia
|
in fasted state
|
| 61230 |
KLF15
|
NOT |
affects_activity of
|
increased circulating insulin level
|
in fasted state
|
| 61231 |
KLF15
|
|
affects_activity of
|
increased circulating insulin level
|
in fed state
|
| 61232 |
KLF15
|
NOT |
affects_activity of
|
gluconeogenesis
|
in fasted state
|
| 61233 |
KLF15
|
|
affects_activity of
|
gluconeogenesis
|
in fed state
|
|
20393151
|
Diabetes mellitus, type II
Insulin resistance
|
|
6,709
|
| 64829 |
RORC
|
|
increases_expression of
|
KLF15
|
|
|
24831725
|
Diabetes mellitus, type II
Insulin resistance
|
|
6,747
|
| 65697 |
circadian rhythm
|
|
affects_expression of
|
KLF15
|
|
| 65698 |
KLF15
|
|
affects_expression of
|
KCNIP2
|
|
| 65699 |
KLF15
|
|
affects_activity of
|
irregular heartbeat
|
|
|
27230643
|
Diabetes mellitus, type II
Insulin resistance
Cardiomyopathy, diabetic
|
|
9,128
|
| 96028 |
KLF15
|
|
increases_expression of
|
BCAT2
|
|
| 96029 |
KLF15
|
|
increases_expression of
|
BCKDHA
|
|
| 96030 |
KLF15
|
|
increases_expression of
|
BCKDHB
|
|
| 96031 |
KLF15
|
|
increases_expression of
|
DBT
|
|
| 96032 |
KLF15
|
|
increases_expression of
|
PPM1K
|
|
|
30354823
|
Gastrointestinal
Metabolic
|
|
9,130
|
| 96115 |
Branched-chain amino acid
|
|
decreases_expression of
|
KLF15
|
|
|
29570613
|
Metabolic
|
|
11,111
|
| 112472 |
hyperglycemia
|
|
increases_quantity of
|
KLF15
|
in skeletal muscle
|
|
30830866
|
Diabetes mellitus, type II
Insulin resistance
|
CIDeRplus